Older Adults Struggle to Get Pfizer’s $225,000-a-Year Heart Drug

Jun 23

Written By Ron Andruff

Older Adults Struggle to Get Pfizer's $225,000-a-Year Heart Drug
Pfizer medication price seen as a barrier to some patients Among 50 patients, some paid thousands, others didn't get it Pfizer Inc.'s new $225,000-a-year heart drug is being labeled by researchers critical of the cost as "the most expensive cardiac medication in history."

Ron Andruff

Number of people buying prescription medications outside U.S. could rise with unemployment

Nine in 10 Concerned About Rising Drug Costs Due to COVID-19